A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 2, 2015, Pages R112-R122

  Foss, Jason D ^a   Wainford, Richard D ^b   Engeland, William C ^c   Fink, Gregory D ^d   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Neuroscience ^*  (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Afferent renal denervation; Hypertension; Salt sensitivity

Indexed keywords

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; VANILLOID RECEPTOR AGONIST; VASOPRESSIN V1 RECEPTOR; SALT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID BALANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY DENERVATION; KIDNEY NERVE; MALE; NERVE FIBER; NONHUMAN; PERIAXONAL DRUG ADMINISTRATION; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RAT; RESISTANT HYPERTENSION; SALT INTAKE; SENSORY NERVE; VALIDATION PROCESS; WEIGHT GAIN; ANIMAL; BLOOD PRESSURE; DENERVATION; DISEASE MODEL; DRUG EFFECTS; HYPERTENSION; INNERVATION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

AFFERENT PATHWAYS; ANIMALS; BLOOD PRESSURE; CAPSAICIN; DENERVATION; DISEASE MODELS, ANIMAL; HYPERTENSION; KIDNEY; MALE; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY;

EID: 84921530301     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00427.2014     Document Type: Article

References (52)

1. Ammons WS. Spinoreticular cell responses to intrarenal injections of bradykinin. Am J Physiol Regul Integr Comp Physiol 255: R994–R1001, 1988.
2. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, for the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370: 1393–1401, 2014.
3. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult- to-control hypertensive patients: prospective case series. Hypertension 60: 1485–1490, 2012.
4. Carlson SH, Osborn JW, Wyss JM. Hepatic denervation chronically elevates arterial pressure in Wistar-Kyoto rats. Hypertension 32: 46–51, 1998.
5. Caverson MM, Ciriello J. Effect of stimulation of afferent renal nerves on plasma levels of vasopressin. Am J Physiol Regul Integr Comp Physiol 252: R801–R807, 1987.
6. Ciriello J. Afferent renal inputs to paraventricular nucleus vasopressin and oxytocin neurosecretory neurons. Am J Physiol Regul Integr Comp Physiol 275: R1745–R1754, 1998.
7. Day TA, Ciriello J. Afferent renal nerve stimulation excites supraoptic vasopressin neurons. Am J Physiol Regul Integr Comp Physiol 249: R368–R371, 1985.
8. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 298: R245–R253, 2010.
9. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 77: 75–197, 1997.
10. Esler MD, Krum H, Schlaich M, Schmieder RE, Bohm M, Sobotka PA. Renal sympathetic denervation for intervention of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 126: 2976–2982, 2012.
11. Fitzgerald M. Capsaicin and sensory neurones—a review. Pain 15: 109–130, 1983.
12. Foss JD, Fink GD, Osborn JW. Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension 61: 806–811, 2013.
13. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 61: 457–464, 2013.
14. Hoagland KM, Maddox DA, Martin DS. Intrarenal infusion of bradykinin elicits a pressor response in conscious rats via a B2-receptor mechanism. Can J Physiol Pharmacol 77: 563–570, 1999.
15. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43: 143–201, 1991.
16. Huang Y, Wang DH. Role of renin-angiotensin-aldosterone system in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol 281: H2143–H2149, 2001.
17. Ishiki K, Morita H, Hosomi H. Reflex control of renal nerve activity originating from the osmoreceptors in the hepato-portal region. J Auton Nerv Syst 36: 139–148, 1991.
18. Jacob F, Ariza P, Osborn JW. Renal denervation chronically lowers arterial pressure independent of dietary sodium intake in normal rats. Am J Physiol Heart Circ Physiol 284: H2302–H2310, 2003.
19. Jacob F, Clark LA, Guzman PA, Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol 289: H1519–H1529, 2005.
20. Jacob F, LaBine BG, Ariza P, Katz SA, Osborn JW. Renal denervation causes chronic hypotension in rats: Role of _1-adrenoceptor activity. Clin Exp Pharmacol Physiol 32: 255–262, 2005.
21. Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 270: 741–743, 1977.
22. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50: 547–556, 2007.
23. Knuepfer MM, Schramm LP. The conduction velocities and spinal projections of single renal afferent fibers in the rat. Brain Res 435: 167–173, 1987.
24. Kopp UC, Cicha MZ, Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension 42: 968–973, 2003.
25. Kopp UC, Jones SY, DiBona GF. Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 295: R1882–R1890, 2008.
26. Krum H, Schlaich MP, Bohm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with intervention- resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 383: 622–629, 2014.
27. Li M, Galligan J, Wang D, Fink G. The effects of celiac ganglionectomy on sympathetic innervation to the splanchnic organs in the rat. Auton Neurosci 154: 66–73, 2010.
28. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Boehm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 60: 419–424, 2012.
29. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Bohm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123: 1940–1946, 2011.
30. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Bohm M. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 128: 132–140, 2013.
31. Morita H, Ishiki K, Hosomi H. Effects of hepatic NaCl receptor stimulation on renal nerve activity in conscious rabbits. Neurosci Lett 123: 1–3, 1991.
32. Morita H, Matsuda T, Furuya F, Khanchowdhury MR, Hosomi H. Hepatorenal reflex plays an important role in natriuresis after high-NaCl food intake in conscious dogs. Circ Res 72: 552–559, 1993.
33. Morita H, Yamashita Y, Nishida Y, Tokuda M, Hatase O, Hosomi H. Fos induction in rat brain neurons after stimulation of the hepatoportal Na-sensitive mechanism. Am J Physiol Regul Integr Comp Physiol 272: R913–R923, 1997.
34. Mulder J, Hokfelt T, Knuepfer MM, Kopp UC. Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats. Am J Physiol Regul Integr Comp Physiol 304: R675–R682, 2013.
35. Nishida Y, Sugimoto I, Morita H, Murakami H, Hosomi H, Bishop VS. Suppression of renal sympathetic nerve activity during portal vein infusion of hypertonic saline. Am J Physiol Regul Integr Comp Physiol 274: R97–R103, 1998.
36. Patel KP, Knuepfer MM. Effect of afferent renal nerve stimulation on blood pressure, heart rate and noradrenergic activity in conscious rats. J Auton Nerv Syst 17: 121–130, 1986.
37. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 60: 1163–1170, 2012.
38. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361: 932–934, 2009.
39. Simon JK, Kasting NW, Ciriello J. Afferent renal nerve effects on plasma vasopressin and oxytocin in conscious rats. Am J Physiol Regul Integr Comp Physiol 256: R1240–R1244, 1989.
40. Smits JF, Brody MJ. Activation of afferent renal nerves by intrarenal bradykinin in conscious rats. Am J Physiol Regul Integr Comp Physiol 247: R1003–R1008, 1984.
41. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159–212, 1999.
42. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Bohm M. Renal sympathetic denervation for intervention of electrical storm: first-in-man experience. Clin Res Cardiol 101: 63–67, 2012.
43. Ulrich-Lai YM, Arnhold MM, Engeland WC. Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol Regul Integr Comp Physiol 290: R1128–R1135, 2006.
44. Ulrich-Lai YM, Fraticelli AI, Engeland WC. Capsaicin-sensitive nerve fibers: a potential extra-ACTH mechanism participating in adrenal regeneration in rats. Microsc Res Tech 61: 252–258, 2003.
45. Ulrich-Lai YM, Marek DJ, Engeland WC. Capsaicin-sensitive adrenal sensory fibers participate in compensatory adrenal growth in rats. Am J Physiol Regul Integr Comp Physiol 283: R877–R884, 2002.
46. Veitenheimer B, Osborn JW. Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress. Am J Physiol Regul Integr Comp Physiol 300: R460–R469, 2011.
47. Wang DH, Li J, Qiu J. Salt-sensitive hypertension induced by sensory denervation: introduction of a new model. Hypertension 32: 649–653, 1998.
48. Wang DH, Wu W, Lookingland KJ. Degeneration of capsaicin-sensitive sensory nerves leads to increased salt sensitivity through enhancement of sympathoexcitatory response. Hypertension 37: 440–443, 2001.
49. Wang H, Wang DH, Galligan JJ. P2Y2 receptors mediate ATP-induced resensitization of TRPV1 expressed by kidney projecting sensory neurons. Am J Physiol Regul Integr Comp Physiol 298: R1634–R1641, 2010.
50. Wang Y, Chen AF, Wang DH. ETA receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol 289: H2005–H2011, 2005.
51. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58: 559–565, 2011.
52. Wu YM, He RR. Biphasic activation of renal afferent by intrarenal artery injection of bradykinin in anesthetized rabbits. Acta Physiol Sinica 51: 651–659, 1999.